Info
Ownership

Samarth Kulkarni - Insider Trading & Ownership

Location: C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Summary: The estimated net worth of Samarth Kulkarni is at least $11.6M dollars as of June 12, 2025. Samarth Kulkarni is the Chief Executive Officer, Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $11.6M.
Signature: /s/ Brent Hatzis-Schoch, Attorney-in-Fact
All Insider Reports: All Insider Reports

Ownership of Samarth Kulkarni

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CRSP	CRISPR Therapeutics AG	Chief Executive Officer, Director	$11.6M	-$5.74M	-33.2%	Mar 20, 2025
BDTX	Black Diamond Therapeutics, Inc.	Director				Jun 12, 2025
CNTA	Centessa Pharmaceuticals plc	Director				Jun 25, 2024
ORKA	Oruka Therapeutics, Inc.	Director				Jun 2, 2025
RPTX	Repare Therapeutics Inc.	Director				Jun 17, 2024

Showing 1 to 5 of 5 entries

Insider Transactions Reported by Samarth Kulkarni:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.